← Leaderboards
Jon B Klein
University Of Louisville
$5,432,267
Attributed
$10,405,435
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,069,532 · 11
By mechanism
U01$6,112,349 · 2
P20$5,866,645 · 6
R01$2,804,538 · 2
R21$286,000 · 1
Top collaborators
- William E. Smoyer9 shared
- Brad H Rovin6 shared
- Haifeng M Wu6 shared
- Laurence A Greenbaum4 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Sara E Watson$2,034,251
- Lori Ann Devlin-Phinney$1,856,389
- Matthew C Cave$12,025,407
- Cheri Alicia Levinson$7,536,321
- Kelli Matheson Bullard Dunn$846,698
Others in their field
Top investigators on “Proteomics”
- David Heimbrook · Leidos Biomedical Research, Inc.$318,825,229
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,612,005
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$70,176,616
- Rolf Apweiler · European Molecular Biology Laboratory$67,677,991
- Daniel Ernest Ford · Johns Hopkins University$67,257,868
Research focus
ProteomicsUrineBloodRenal Glomerular DiseaseFutureKidney FailureEnd Stage Renal FailureKidney DiseasesProteomeInjuryFundingPreventResearch PersonnelCollaborationsCohortPathogenesisChildProspectiveDiabetes MellitusMemberDesignMembranous GlomerulonephritisMetabolic DiseasesAdult
Grant awards (30)
Louisville Clinical And Translational Research Center (LCTRC)$2,327,272
P20 · FY2025 · GM · contact PI
CUREGN 3.0 - Pediatric Nephrology Consortium - PCC$953,728
U01 · FY2025 · DK
Administrative Core (AC)$338,117
P20 · FY2025 · GM · contact PI
Louisville Clinical And Translational Research Center (LCTRC)$2,336,825
P20 · FY2024 · GM · contact PI
CUREGN 3.0 - Pediatric Nephrology Consortium - PCC$925,000
U01 · FY2024 · DK
Administrative Core (AC)$338,117
P20 · FY2024 · GM · contact PI
CUREGN 2.0 - Midwest Pediatric Nephrology Consortium - PCC$1,083,678
U01 · FY2020 · DK
Integrating Proteomics and Metabolomics to Understand Pediatric Glomerular Disease Pathophysiology and Prognosis$345,860
R01 · FY2020 · DK
CUREGN 2.0 - Midwest Pediatric Nephrology Consortium - PCC$1,181,399
U01 · FY2019 · DK
Integrating Proteomics and Metabolomics to Understand Pediatric Glomerular Disease Pathophysiology and Prognosis$351,649
R01 · FY2019 · DK
Integrating Proteomics and Metabolomics to Understand Pediatric Glomerular Disease Pathophysiology and Prognosis$357,277
R01 · FY2018 · DK
Integrating Proteomics and Metabolomics to Understand Pediatric Glomerular Disease Pathophysiology and Prognosis$362,397
R01 · FY2017 · DK
Integrating Proteomics and Metabolomics to Understand Pediatric Glomerular Disease Pathophysiology and Prognosis$379,355
R01 · FY2016 · DK
Forecasters of futute and progressive CDK in patients with microvascular glomerul$190,212
U01 · FY2013 · DK
Forecasters of futute and progressive CDK in patients with microvascular glomerul$470,289
U01 · FY2012 · DK
Forecasters of futute and progressive CDK in patients with microvascular glomerul$445,180
U01 · FY2011 · DK
Forecasters of futute and progressive CDK in patients with microvascular glomerul$365,321
U01 · FY2010 · DK
Forecasters of futute and progressive CDK in patients with microvascular glomerul$100,000
U01 · FY2010 · DK
Forecasters of futute and progressive CDK in patients with microvascular glomerul$397,542
U01 · FY2009 · DK
COBRE: LOUISVILLE RES FOUND INC: CORE E: PROTEOMICS FACILITY$94,251
P20 · FY2008 · RR · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE E: PROTEOMICS FACILITY$99,168
P20 · FY2007 · RR · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE E: PROTEOMICS FACILITY$138,754
P20 · FY2006 · RR · contact PI
COBRE: LOUISVILLE RES FOUND INC: CORE E: PROTEOMICS FACILITY$89,721
P20 · FY2005 · RR
CORE--PROTEOMICS FACILITY$104,420
P20 · FY2004 · RR
PROTEOMIC ANALYSIS OF HIPPOCAMPAL HYPOXIC VULNERABILITY$252,000
R01 · FY2003 · HL
Proteomic Analysis of Diabetic Nephropathy$143,000
R21 · FY2003 · DK
PROTEOMIC ANALYSIS OF HIPPOCAMPAL HYPOXIC VULNERABILITY$252,000
R01 · FY2002 · HL
Proteomic Analysis of Diabetic Nephropathy$143,000
R21 · FY2002 · DK
PROTEOMIC ANALYSIS OF HIPPOCAMPAL HYPOXIC VULNERABILITY$252,000
R01 · FY2001 · HL
PROTEOMIC ANALYSIS OF HIPPOCAMPAL HYPOXIC VULNERABILITY$252,000
R01 · FY2000 · HL